查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611903

3D 生物列印市场：按组件、技术和最终用户划分 - 2025-2030 年全球预测

3D Bioprinting Market by Component (3D Bioprinters, Bioinks), Technology (Extrusion-based Bioprinting, Inkjet-based Bioprinting, Laser-assisted Bioprinting), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年3D生物列印市场规模为17.9亿美元，预计2024年将达到21.4亿美元，复合年增长率为19.89%，预计到2030年将达到63.9亿美元。

3D生物列印是一项创新技术，专注于透过使用逐层技术精确创建三维结构来生产生物和组织学材料。 3D 生物列印的需求在于其彻底改变再生医学、医学和生物工程、解决可移植器官的严重短缺、透过精确的组织模型简化药物开发以及改善患者治疗效果的潜力。应用范围从创建用于疾病建模的类器官到製造植入和义肢，最终用途包括医院、研究机构和生物技术公司。影响该市场的关键成长要素包括生医材料的进步、研发资金的增加以及需要创新治疗的慢性疾病盛行率的上升。最近的技术创新正在扩大复杂组织结构的生物列印和模仿人体组织的生物墨水的使用的机会。市场动态是由生物列印公司和医疗保健提供者之间合作开发临床可行的产品推动的，政府以政策和财政奖励形式的支持正在推动进一步扩张。然而，其局限性包括高製造成本、可扩展性问题、道德问题以及阻碍快速商业化的严格监管框架。一个重要的障碍是实现生物列印组织的血管生成和长期功能的技术难度。应对这些挑战需要引导创新，开发多材料和多细胞生物列印能力，改进生物墨水配方，并提高生物列印过程的自动化程度。此外，涉及生物工程师、材料科学家和医学专业人员的跨学科研究对于该领域的进步至关重要。虽然组织工程、基因编辑整合和个人化医疗框架开发等新兴市场为成长提供了肥沃的土壤，但学术界和工业界必须为市场扩张创造有利的环境，促进工业界和监管机构之间的合作至关重要。该市场正处于起步阶段，但正在快速成长，持续的创新和投资是抓住这段变革时期时期潜在机会的关键。

主要市场统计
基准年[2023] 17.9亿美元
预计年份 [2024] 21.4亿美元
预测年份 [2030] 63.9亿美元
复合年增长率（%） 19.89%

市场动态：揭示快速发展的 3D 生物列印市场的关键市场洞察

供需的动态交互作用正在改变 3D 生物列印市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对疾病建模和组织工程的需求不断增长
    • 药物和锭剂研究中越来越多地采用 3D 生物列印
  • 市场限制因素
    • 对合适印刷材料的可扩展性和可得性的担忧
  • 市场机会
    • 增加为博士学术计划提供的研究经费
    • 3D 生物列印机和生物材料的爆炸性进步
  • 市场挑战
    • 需要资金进行细胞生物学研究

波特五力：驾驭 3D 生物列印市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 3D 生物列印市场的外部影响

外部宏观环境因素在塑造 3D 生物列印市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解 3D 生物列印市场的竞争格局

对 3D 生物列印市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵3D生物列印市场供应商绩效评估

FPNV 定位矩阵是评估 3D 生物列印市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 3D 生物列印市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 3D 生物列印市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对疾病模型和组织工程的需求不断增长
      • 药物和锭剂研究中越来越多地采用 3D 生物列印
    • 抑制因素
      • 对合适印刷材料的扩充性和可用性的担忧
    • 机会
      • 增加为博士学术计划提供的研究经费
      • 3D 生物列印机和生医材料的爆炸性进步
    • 任务
      • 进行细胞生物学研究需要大量资金
  • 市场区隔分析
    • 组成部分：扩大可适应各种应用的 3D 生物列印机的使用
    • 最终用户：3D生物列印在製药和生物技术公司中的使用正在蓬勃发展
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 3D 生物列印市场：按组成部分

  • 3D生物列印机
  • 生物墨水

第 7 章 3D 生物列印市场：依技术分类

  • 挤压法生物列印
  • 基于喷墨的生物列印
  • 雷射辅助生物列印

第 8 章 3D 生物列印市场：依最终用户划分

  • 製药和生物技术公司
  • 调查机构

第9章美洲3D生物列印市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太3D生物列印市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的3D生物列印市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Readyly3D推出先进的生物墨水，可精确列印复杂组织
    • BIO INX 与 Rousselot 合作推进 3D 生物列印材料
    • Nexa3D 透过收购 Essentium 扩大市场规模
  • 战略分析和建议

公司名单

  • 3D BioFibR
  • 3D Bioprinting Solutions
  • 3D Systems Corporation
  • Advanced Solutions, Inc.
  • Aspect Biosystems Ltd.
  • Avay Biosciences Private Limited
  • Axiom Space, Inc.
  • Axolotl Biosystems Ltd.
  • BICO Group AB
  • Brinter Inc.
  • Cellbricks GmbH
  • CollPlant Biotechnologies Ltd.
  • Cyfuse Biomedical KK
  • Desktop Metal, Inc.
  • Fluicell AB
  • FluidForm, Inc.
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • GeSiM
  • Inventia Life Science Pty Ltd.
  • Medprin Regenerative Medical Technologies Co., Ltd.
  • Merck KGaA
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Precise Bio Inc.
  • Prellis Biologics
  • PrintBio, Inc
  • REGEMAT 3D SL
  • regenHU Ltd.
  • Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
  • ROKIT Healthcare Inc.
  • TheWell Bioscience Inc.
  • UPM-Kymmene Corporation
  • UpNano GmbH
Product Code: MRR-43649B5EE3C4

The 3D Bioprinting Market was valued at USD 1.79 billion in 2023, expected to reach USD 2.14 billion in 2024, and is projected to grow at a CAGR of 19.89%, to USD 6.39 billion by 2030.

3D bioprinting is an innovative technology focused on the precise creation of three-dimensional structures using a layer-by-layer method to produce biological and tissue-like materials. Defined by its potential to revolutionize regenerative medicine, pharmaceuticals, and bioengineering, the necessity of 3D bioprinting arises from its ability to address critical shortages in transplantable organs, streamline drug development with accurate tissue models, and customize patient-specific treatments. Its applications span from fabricating organoids for disease modeling to crafting implants and prosthetics, with end-use segments including hospitals, research institutions, and biotechnology companies. Key growth factors influencing this market include advancements in biomaterials, increased funding for R&D, and the rising prevalence of chronic diseases necessitating innovative treatments. Recent technological breakthroughs have expanded opportunities in bioprinting complex tissue structures and using bioinks mimicking human tissues. Market dynamics are propelled by collaborations between bioprinting firms and healthcare providers to develop clinically viable products, while governmental support in the form of policies and financial incentives facilitates further expansion. However, limitations include high manufacturing costs, scalability issues, ethical concerns, and stringent regulatory frameworks that challenge rapid commercialization. A significant barrier remains the technical difficulty in achieving vascularization and long-term functionality of bioprinted tissues. Addressing these challenges involves steering innovation towards developing multi-material and multicellular bioprinting capabilities, refining bioink formulations, and enhancing automation in bioprinting processes. Furthermore, interdisciplinary research involving bioengineers, material scientists, and medical practitioners is crucial for advancing this field. Emerging areas such as tissue engineering, gene editing integration, and the development of personalized medicine frameworks offer fertile ground for growth, while fostering collaboration among academia, industry, and regulatory bodies is essential to nurture a favorable environment for market expansion. With the market in a nascent yet rapidly growing stage, continuous innovation and investment are key to capturing potential opportunities in this transformative landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 6.39 billion
CAGR (%) 19.89%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Bioprinting Market

The 3D Bioprinting Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for disease modeling and tissue engineering
    • Increase in deployment of 3D bioprinting across research of drugs and pills
  • Market Restraints
    • Concern over scalability and availability of suitable printing materials
  • Market Opportunities
    • Increasing research funding provided to doctoral academic projects
    • Proliferation in advancements of 3D bioprinters and biomaterials
  • Market Challenges
    • Capital intensive to perform cell biology research

Porter's Five Forces: A Strategic Tool for Navigating the 3D Bioprinting Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Bioprinting Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Bioprinting Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Bioprinting Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Bioprinting Market

A detailed market share analysis in the 3D Bioprinting Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Bioprinting Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Bioprinting Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Bioprinting Market

A strategic analysis of the 3D Bioprinting Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Bioprinting Market, highlighting leading vendors and their innovative profiles. These include 3D BioFibR, 3D Bioprinting Solutions, 3D Systems Corporation, Advanced Solutions, Inc., Aspect Biosystems Ltd., Avay Biosciences Private Limited, Axiom Space, Inc., Axolotl Biosystems Ltd., BICO Group AB, Brinter Inc., Cellbricks GmbH, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal, Inc., Fluicell AB, FluidForm, Inc., FUJIFILM Corporation, GE HealthCare Technologies Inc., GeSiM, Inventia Life Science Pty Ltd., Medprin Regenerative Medical Technologies Co., Ltd., Merck KGaA, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Precise Bio Inc., Prellis Biologics, PrintBio, Inc, REGEMAT 3D S.L., regenHU Ltd., Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd., ROKIT Healthcare Inc., TheWell Bioscience Inc., UPM-Kymmene Corporation, and UpNano GmbH.

Market Segmentation & Coverage

This research report categorizes the 3D Bioprinting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across 3D Bioprinters and Bioinks.
  • Based on Technology, market is studied across Extrusion-based Bioprinting, Inkjet-based Bioprinting, and Laser-assisted Bioprinting.
  • Based on End-user, market is studied across Pharmaceutical & Biotechnology Companies and Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for disease modeling and tissue engineering
      • 5.1.1.2. Increase in deployment of 3D bioprinting across research of drugs and pills
    • 5.1.2. Restraints
      • 5.1.2.1. Concern over scalability and availability of suitable printing materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research funding provided to doctoral academic projects
      • 5.1.3.2. Proliferation in advancements of 3D bioprinters and biomaterials
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive to perform cell biology research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
    • 5.2.2. End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 3D Bioprinting Market, by Component

  • 6.1. Introduction
  • 6.2. 3D Bioprinters
  • 6.3. Bioinks

7. 3D Bioprinting Market, by Technology

  • 7.1. Introduction
  • 7.2. Extrusion-based Bioprinting
  • 7.3. Inkjet-based Bioprinting
  • 7.4. Laser-assisted Bioprinting

8. 3D Bioprinting Market, by End-user

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Organizations

9. Americas 3D Bioprinting Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Bioprinting Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Bioprinting Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues
    • 12.3.2. BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials
    • 12.3.3. Nexa3D Expands Market Footprint with the Acquisition of Essentium
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D BioFibR
  • 2. 3D Bioprinting Solutions
  • 3. 3D Systems Corporation
  • 4. Advanced Solutions, Inc.
  • 5. Aspect Biosystems Ltd.
  • 6. Avay Biosciences Private Limited
  • 7. Axiom Space, Inc.
  • 8. Axolotl Biosystems Ltd.
  • 9. BICO Group AB
  • 10. Brinter Inc.
  • 11. Cellbricks GmbH
  • 12. CollPlant Biotechnologies Ltd.
  • 13. Cyfuse Biomedical K.K.
  • 14. Desktop Metal, Inc.
  • 15. Fluicell AB
  • 16. FluidForm, Inc.
  • 17. FUJIFILM Corporation
  • 18. GE HealthCare Technologies Inc.
  • 19. GeSiM
  • 20. Inventia Life Science Pty Ltd.
  • 21. Medprin Regenerative Medical Technologies Co., Ltd.
  • 22. Merck KGaA
  • 23. Organovo Holdings Inc.
  • 24. Pandorum Technologies Pvt. Ltd.
  • 25. Precise Bio Inc.
  • 26. Prellis Biologics
  • 27. PrintBio, Inc
  • 28. REGEMAT 3D S.L.
  • 29. regenHU Ltd.
  • 30. Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
  • 31. ROKIT Healthcare Inc.
  • 32. TheWell Bioscience Inc.
  • 33. UPM-Kymmene Corporation
  • 34. UpNano GmbH

LIST OF FIGURES

  • FIGURE 1. 3D BIOPRINTING MARKET RESEARCH PROCESS
  • FIGURE 2. 3D BIOPRINTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D BIOPRINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. 3D BIOPRINTING MARKET DYNAMICS
  • TABLE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023